COVID-19

HHS touts universal flu, coronavirus vaccine initiative while casting doubt on future of seasonal Covid-19 shots | CNN The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal flu vaccine that could protect against multiple virus strains with pandemic potential, including H5N1 avian influenza. Meg Tirrell, Brenda Goodman CNN

...

Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay Moderna is deprioritizing< | Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its operating expenses. The biotech disclosed the changes alongside news of a delay to the expected approval of the vaccine in older adults. Nick Paul Taylor Fierce Biotech

...

FDA chief says they're looking at whether to approve COVID shots for next winter FDA Commissioner Dr. Marty Makary said there is a "void of data" on the COVID booster shots. CBS News

...

His answer marks a change from during the Biden administration, when FDA officials backed plans to routinely update the COVID-19 vaccines each year.

...

Studies across 14 nations show 25% to 30% rate of long COVID Among the 25% of participants in 1 study who said they experienced long-COVID symptoms, 13% reported sleep disorders. CIDRAP

A new study in BMJ Global Health across 13 middle- and high-income countries reveals that 25% of patients reported symptoms of long COVID after symptomatic COVID-19, and long COVID is significantly more prevalent in participants from less wealthy nations and in patients of Arab or North African ethnicity.

...